These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30261987)

  • 1. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
    Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
    Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of illness severity scores to predict mortality in patients hospitalized with respiratory deterioration of idiopathic pulmonary fibrosis.
    Hyams C; Hettle D; Bibby A; Adamali HA; Barratt SL
    QJM; 2021 Nov; 114(8):559-567. PubMed ID: 32609364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
    Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
    Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.
    Oishi K; Aoe K; Mimura Y; Murata Y; Sakamoto K; Koutoku W; Matsumoto T; Ueoka H; Yano M
    Intern Med; 2016; 55(24):3551-3559. PubMed ID: 27980253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
    Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
    Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
    Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
    Suzuki T; Hozumi H; Miyashita K; Kono M; Suzuki Y; Karayama M; Furuhashi K; Hasegawa H; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Yokomura K; Nakamura H; Suda T
    Sci Rep; 2021 Apr; 11(1):9120. PubMed ID: 33907284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF; Wu N; Chuang CC; Wang R; Pan X; Benjamin NN; Devercelli G; Coultas DB
    J Manag Care Spec Pharm; 2016 Apr; 22(4):414-23. PubMed ID: 27023695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
    Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.
    Cao MS; Sheng J; Wang TZ; Qiu XH; Wang DM; Wang Y; Xiao YL; Cai HR
    Chin Med J (Engl); 2019 Sep; 132(18):2177-2184. PubMed ID: 31490258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis.
    Yokoyama T; Kondoh Y; Taniguchi H; Kataoka K; Kato K; Nishiyama O; Kimura T; Hasegawa R; Kubo K
    Intern Med; 2010; 49(15):1509-14. PubMed ID: 20686281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.